2019/06/28 15:59:05 | |
---|---|
Price | |
120.80 EUR | |
Difference | 3.07% (3.60) |
ISIN | CH0019396990 |
Symbol | YPSN |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5,849 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 119.00 EUR |
High | 120.80 EUR |
Low | 119.00 EUR |
Close (prev. day) | 117.20 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/03/26 |
![]() |
Global Strategy 2Q 2024 |
![]() |
2019/06/28 15:59:05 | |
---|---|
Price | |
120.80 EUR | |
Difference | 3.07% (3.60) |
ISIN | CH0019396990 |
Symbol | YPSN |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5,849 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 119.00 EUR |
High | 120.80 EUR |
Low | 119.00 EUR |
Close (prev. day) | 117.20 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +16.83% | -2.97% | -21.26% |
Perf (abs.) | +17.40 | -3.70 | -32.62 |
Beta | 0.50 | 0.70 | 0.88 |
Volatility | 26.32 | 23.72 | 29.99 |
Ø price 5 days | Ø volume 5 days (pcs.) | 117.84 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 112.34 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 112.20 EUR (9) |
Ø price 250 days | Ø volume 250 days (pcs.) | 115.27 EUR (5) |
YTD High | date | 122.00 EUR (2019/05/22) |
YTD Low | date | 99.00 EUR (2019/01/30) |
52 Weeks High | date | 129.70 EUR (2018/08/30) |
52 Weeks Low | date | 98.85 EUR (2018/12/21) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/08/16 | 17:31 | 411.00 CHF | 1.46 | 237 |
London Stock Exchange | 2024/05/21 | 16:12 | 339.50 CHF | 0.16 | 1 |
Frankfurt | 2019/06/28 | 15:43 | 120.60 EUR | 0.00 | 3 |
FINRA other OTC Issues | 2024/08/02 | 15:48 | 452.47 USD | 0.00 | 1 |
Berlin | 2019/06/28 | 15:59 | 120.80 EUR | 0.00 | 5 |
YPSOMED HOLDING AG |
- - |
Brunnmattstrasse 6 - 3401 Burgdorf |
Telefon: +41-34-424-41-11 |
Fax: + |
E-mail: info@ypsomed.com |
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. It operates through the following segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others. The Ypsomed Diabetes Care segment is involved in the products that are sold directly to hospitals, doctors, pharmacies, and patients via Ypsomed subsidiaries and distributors. The Ypsomed Delivery Systems segment focuses on the pharmaceutical and biotech customers with injection systems and related services. The Others segment consists of Ypsotec and properties not used for operational purposes. The company was founded by Wilhelm Michel on December 29, 2003, and is headquartered in Burgdorf, Switzerland. |
Simon Michel | Chairman of Managing Board |
Frank Mengis | Member of Executive Committee |
Michael Zaugg | Member of Executive Committee |
Niklaus Ramseier | Member of Executive Committee |
Sébastien Delarive | Member of Executive Committee |
Ulrike Bauer | Member of Executive Committee |
Martin C. Münchbach | Member of the administrative board |
Betül Susamis Unaran | Member of the administrative board |
Paul R. Fonteyne | Member of the administrative board |
Gilbert Achermann | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer